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Abstract
Chemotaxis has been studied by classical methods that measure chemotactic and random motility responses in vitro, but
these methods do not evaluate the total number and phenotype of migrating leukocytes simultaneously. Our objective was
to develop and validate a novel assay, combined Boyden-flow cytometry chemotaxis assay (CBFCA), for simultaneous
quantification and phenotypification of migrating leukocytes. CBFCA exhibited several important advantages in comparison
to the classic Boyden chemotaxis assay (CBCA): 1) improved precision (intra-assay coefficients of variation (CVs): CBFCA-4.7
and 4.8% vs. CBCA-30.1 and 17.3%; inter-observer CVs: CBFCA-3.6% vs. CBCA 30.1%); 2) increased recovery of cells, which
increased assay to provide increased sensitivity; 3) high specificity for determining the phenotype of migrating/attracted
leukocytes; and 4) reduced performance time (CBFCA 120 min vs. CBCA 265 min). Other advantages of CBFCA are: 5)
robustness, 6) linearity, 7) eliminated requirement for albumin and, importantly, 8) enabled recovery of migrating leukocytes
for subsequent studies. This latter feature is of great benefit in the study of migrating leukocyte subsets. We conclude that
the CBFCA is a novel and improved technique for experiments focused on understanding leukocyte trafficking during the
inflammatory response.
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Introduction
Leukocyte infiltration is a crucial event of inflammation. This
process is regulated by several molecules, including chemoattrac-
tants and cellular adhesion molecules [1]. Chemoattraction is
termed chemotaxis when the ligand gradient is soluble. Chemo-
taxis is described as an ensemble of cell activities that are precisely
orchestrated in space and time, consisting of highly dynamic cell
shape rearrangements accompanied by rapid adhesion–de-adhe-
sion cycling and directional movement [2].
Different models for investigating leukocyte chemotaxis have
been developed to measure chemotactic and random motility
responses in vitro. These assays provide information on the
locomotion of leukocytes, which is not only of physiological
interest, but also important in furthering our understanding of the
inflammatory response. Although these assays do not necessarily
mimic in vivo conditions, they are useful tools for studying the
cellular functions that occur in living tissues [3,4,5,6].
The most common methods used to evaluate chemotaxis are
those in which leukocytes migrate through a micropore membrane
[7], of which the Boyden model is an early example [3]. Although
this technique provides an estimation of the relative leukocyte
chemotactic activity of soluble substances, it is suggested that it
gives partial and sometimes misleading information, and should be
supplemented with other methods including visual assays [8].
Consequently, the Boyden chamber technique has been modified
over the years [9,10,11]; however, none of these modifications
allow the quantification of total migrating leukocytes concurrently
with the determination of their phenotype.
Phenotypification of migrating leukocytes is not required for
chemotaxis studies that utilize purified leukocyte subsets, such as
neutrophils [12] and monocytes [13]. However, in many
experimental paradigms, the simultaneous evaluation of distinct
leukocyte subsets is crucial [12,14,15], and this typically requires
separate assays. To associate specific inflammatory responses with
distinct leukocyte subsets, investigators require an improved
method for studying the density and phenotype of diverse
leukocyte subsets simultaneously. In the present study we describe
and validate an improved CBFCA, which allows the accurate
quantification and phenotypification of different migrating leuko-
cyte subsets in a single assay. This CBFCA allows the accurate
quantification and recovery of the migrating leukocytes for
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28771subsequent phenotypification and characterization in a single
assay, which facilitates understanding of leukocyte trafficking
during the inflammatory response.
Materials and Methods
Ethics statement
This study was approved by the institutional review board of the
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes in
Mexico City (Register 212250-02121). Written and informed
consent was obtained from each subject prior to inclusion in the
study.
Isolation of leukocytes
Peripheral blood samples from healthy female donors (age 30–
40 years) were collected into heparinized tubes. Total leukocytes
were isolated using Polymorphprep
TM (Axis-Shield, MA, USA)
density gradient according to the manufacturers instructions.
Following centrifugation, both bands of leukocytes (mono-and
polymorphonuclear) were recovered and mixed. Total leukocytes
were washed twice in calcium and magnesium-free 1X phosphate
buffered saline (PBS) at 4uC and resuspended in Dulbeccos
modified Eagle’s medium (DMEM) (GIBCO Invitrogen, CA,
USA). Leukocyte viability was assessed by trypan blue exclusion
and the leukocyte count was determined using a Beckman Coulter
AcT 5 Diff Hematology Analyzer (Beckman Coulter, CA, USA).
Viability was greater than 97%, with negligible contamination by
red blood cells. Leukocyte suspensions were stored at 37uC and
used within an hour of isolation.
CBCA
The classic chemotaxis assay was performed according to the
method described by Snyderman, et al. [16] using modified
Boyden chambers (BY312; Neuro Probe, MD, USA) and a double
membrane modification [17] (Fig. 1A). The lower well of the
chamber was filled creating a slight positive meniscus with 1.2 ml
of chemotactic (either medium as control or 10
26 M N-Formil-
Met-Leu-Phe (fMLP) (Sigma-Aldrich, MO, USA) diluted in
DMEM). This concentration of fMLP has been shown to be
optimal for inducing migration of leukocytes [18]. Two mem-
branes were used together to separate the chamber wells: a
5 mm pore size polycarbonate membrane, 22 mm in thickness
Figure 1. CBCA & CBFCA. A) CBCA includes a permeable polycarbonate membrane and a second cell impermeable cellulose membrane directly
beneath to trap attracted cells. These membranes separate the upper well containing leukocytes and the lower well containing the chemotactic.
Attracted leukocytes are counted in the cellulose membrane under light microscopy in different focal planes (magnification). White arrows represent
the leukocytes trapped and agglutinated into the cellulose membrane, and the yellow arrow represents its pores. Light microscopy: magnification
x400; Red bar 10 mm. B) CBFCA includes a single polycarbonate membrane between the wells. Attracted leukocytes in the lower well are counted by
flow cytometry and their number increases lineally with the length of interval. The leukocyte phenotype can also be determined in this step.
doi:10.1371/journal.pone.0028771.g001
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cells, and a 8 mm pore size cellulose membrane, 160 mmi n
thickness (SCWP01300, Millipore Corporation) directly above the
lower well to trap the cells. Then, the thumb nut was placed and
tightened until finger-tight. The upper and lower wells were then
filled simultaneously creating a slight positive meniscus, the lower
with 500 mL of chemotactic and the upper with 500 mLo f
leukocyte suspension containing 5610
5 leukocytes. Boyden
chambers were incubated in a humidified atmosphere at 37uC
for 90 min [13], and the horizontal position was assured using a
bubble level device. Following incubation, the cellulose membrane
was removed, washed in 1X PBS, fixed with methanol, stained
with Harris hematoxilin-eosin, and mounted on glass slides using
EntellanH (Electron Microscopy Sciences, PA, USA) with the
upper surface facing up. Migrating total leukocytes were counted
by light microscopy at 400 X using an oil-immersion objective.
Two perpendicular diameters were counted on each membrane
(.100 fields per membrane) [13,19] and the result was scored as
the number of attracted leukocytes per membrane. Leukocytes
attracted by the control were subtracted in all cases.
CBFCA
The combined chemotaxis assay was performed under the same
conditions described for the classic method. However, only the
polycarbonate membrane was used (Fig. 1B). Following incuba-
tion, the leukocyte suspension in the lower well was removed and
centrifuged at 5006g for 5 min at room temperature. The pellet
containing attracted leukocytes was fixed with 500 mL of Optilyse
B (Beckman Coulter), washed and resuspended in 500 mLo f1 X
PBS, and leukocytes were counted using a flow cytometer (FC500;
Beckman Coulter). Leukocyte counting by flow cytometry (using a
medium flow rate) was evaluated at six different counting length
intervals (30, 60, 100, 200, 300 sec) using 10
26 M fMLP and a
standard leukocyte sample. As for CBCA, leukocytes attracted by
the control were subtracted in all cases.
Validation of CBFCA
For validation of the performance of this proposed assay, we
have considered the classical parameters of precision, accuracy,
sensitivity, and specificity.
Precision. The intra-assay variation was determined by per-
forming two sets of assays, using 10
26 M fMLP as chemotactic
and leukocytes from the same person. Set 1 included 12 assays and
set 2 included 15 assays. Both sets were performed using both
methods CBCA or CBFCA, and using two different leukocyte
samples. The inter-observer variation was determined by using 6
different expert observers/operators, where 3 counted by
microscopy (CBCA) and 3 counted by flow cytometry for
100 sec (CBFCA). The coefficients of variation were calculated
by dividing the standard deviation of the estimates by their mean.
Accuracy and sensitivity. The classical definitions of these
validation terms are difficult to apply to this assay because of the
lack of an accepted ‘‘gold standard’’. To address these concepts,
we performed 10 independent assays in triplicate (each
independent assay included 1 sample of leukocytes): 5 assays
using 10
26 M fMLP as standard chemotactic, and 5 assays using
plasma obtained from healthy donors as biological chemotactic
[20]. Assays were performed using CBCA or CBFCA. We
calculated the recovery of the cells after the assay and then
considered the accuracy and sensitivity of the counting technique
to provide valid measurements.
Specificity. Again, the concept of specificity is difficult to
apply to this assay. To demonstrate the ability of the CBFCA to
distinguish among phenotypes in a mixed population of
leukocytes, we used flow cytometry to assess the leukocyte
phenotype before and after performing CBFCA, using 10 mLo f
each of the following fluorescent monoclonal antibodies (Beckman
Coulter): CD45-FITC (PN IM2643) for total leukocytes, CD3-
PC7 (6607100) for T lymphocytes, CD19-PC5 (PN IM2643) for B
lymphocytes, CD14-ECD (PN IM2707U) for monocytes, and
CD56-PE (PN IM2073) for NK cells. Leukocyte subsets were
analyzed within the CD45+ region considering 10,000 events.






cells. Specificity of CBFCA was observed by comparing the
leukocyte subset proportions before and after assay. Although we
only analyzed general leukocyte subsets, each laboratory will chose
specific antibodies according to its needs.
Robustness
We evaluated the leukocyte chemotaxis of a biological
chemotactic at different concentrations in time course experi-
ments. CBFCAs were performed using both undiluted and diluted
plasma (1:50 and 1:100). Since CBFCA also determines the
phenotype of attracted leukocytes and each leukocyte subset has
different responsiveness [21], we established the robustness of the
incubation time for each leukocyte subset in CBFCA. Assays at
different incubation times (60, 90 and 120 min) were performed
using plasma as biological chemotactic.
Linearity










26 M fMLP as chemotactics.
Neutrophils were purified with Polymorphprep
TM solution (Axis
shield), and monocytes were positively separated by magnetic cell
sorting, using the Monocyte Isolation Kit (Miltenyi Biotec, CA,
USA), according to the manufacturer’s instructions.
Use of Albumin
It has been reported that an exogenous protein source is
required to obtain reproducible results when chemotaxis is
evaluated using cellulose membranes [7]. However, it is unknown
if addition of albumin effects the quantification of the CBFCA.
This was evaluated by performing CBFCAs using medium and
10
26 M fMLP, in the absence or presence of two previously
reported concentrations of human albumin (HA) (wt/vol): 0.1%
[22,23,24] and 2% [25,26].
Statistical analyses
The data were examined initially by the Shapiro-Wilk test for
normal distribution. Since they were normally distributed, T tests,
ANOVA and post-hoc tests were used according to the
homogeneity of variances. Statistical analyses were performed
using SPSS version 18.0. A P value of,0.05 was considered
statistically significant.
Results and Discussion
Comparison between CBCA and CBFCA
Several variations of the original Boyden technique have been
reported since it was described [8,27]. Snyderman introduced the
double membrane assay (CBCA), which is widely used
[9,16,17,19]. Migrating leukocytes pass through the polycarbonate
membrane by a process similar to diapedesis [1] and become
trapped in the cellulose membrane. These trapped leukocytes
were counted by light microscopy. Although this technique is
commonly used to investigate chemotaxis in vitro [3,27,28], the
assessment of the number of attracted leukocytes is subjective and
Combined Boyden-Flow Cytometry Assay
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imately 2 hrs per membrane/assay. Variation arises due to
trapping and clustering of the leukocytes in different focal planes
of the cellulose membrane (Fig. 1A). In CBFCA, the cellulose
membrane was eliminated, enabling recovery of leukocytes in a
fluid medium after passing through the polycarbonate membrane.
Interval lengths of 30, 60, 100, 200, 300 sec were used for
leukocyte counting by flow cytometry (Fig. 1B). Here, we
demonstrated that the leukocyte count increased logarithmically
with the interval length. We recommend that each laboratory
chooses this parameter according its experimental design. We
selected 300 sec because it maximizes the number of counted cells
and remains in the linear portion of the relationship between time
and leukocyte count.
Validation of CBFCA
Precision. To determine the precision of both assays, we
calculated the intra-assay variation and a homologous of an
inter-assay, the inter-observer variation. In both sets of assays, the
intra-assay CV was higher in CBCA (30.1 and 17.3%) than in
CBFCA (4.7 and 4.8%) (Fig. 2A and B). In addition, the inter-
observer CV was higher in CBCA (30.1%) than in CBFCA (3.6%)
(Fig. 2C and D). The high inter-observer CV in CBCA was
attributed to the assay rather than the observers, since the three
observers had high expertise and experience in microscopy. These
data demonstrate that CBFCA exhibits improved precision over
CBCA.
Accuracy and sensitivity. Using fMLP as the standard
chemical chemoattractant and human plasma [20] as a biological
chemoattractant, we determined the accuracy of both methods.
While CBFCA determined 90% of the leukocyte chemotaxis of
plasma, CBCA only determined 29%. In addition, the counting
range in the CBCA method was 200 – 2500 cells per membrane
(up to 0.5 % of 5610
5 placed cells) and in the CBFCA method was
markedly expanded to 100–100,000 cells per tube (up to 20% of
5610
5 placed cells). Furthermore, when we used purified
leukocyte subsets, CBFCA increased its counting range even
further to 100 – 250,000 cells (up to 50% of 5610
5 placed cells).
These data strongly suggest that the sensitivity and range of
measurability of CBFCA is superior to CBCA. It is apparent that
Figure 2. Precision: Intra-assay and inter-observer variation. A&B) Two sets of assays were performed by CBCA or CBFCA, set 1 includes 12
assays (gray diamonds) and set 2 includes 15 assays (black squares). Intra-assay coefficient of variation (CV) in CBCA was higher than in CBFCA in both
sets (30.1 and 17.3% vs 4.7 and 4.8%). D&C) Three of these assays were counted by three different observers/operators using microscopy or flow
cytometry. The inter-observer CV in CBCA was higher than in CBFCA (30.1 vs 3.6%). Data are shown as means6SD of three independent assays
counted in triplicate.
doi:10.1371/journal.pone.0028771.g002
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used for counting by flow cytometry will have a significant impact
on the ability of the method to produce valid measurements. We
recommend that each laboratory consider these parameters before
using this assay and individualize the parameters according to
their experimental conditions and desired end-points.
Specificity. It was not possible to determine the specificity
of CBCA, since in this step the attracted leukocytes were
trapped into the cellulose membrane and the phenotype
determination was subjective. The specificity of CBFCA was
evaluated by determination of the phenotype of attracted
leukocytes using specific conjugated antibodies and flow
cytometry (Fig. 3A). Our data showed that 10
26 Mf M L Pa n d
plasma exhibited specific leukocyte chemotactic activity, since
the proportion of leukocyte subsets differed before and after
assay: T lymphocytes (p=0.009 and 0.019), monocytes (p=ns
and 0.022), NK cells (p=0.004 and 0.005), and granulocytes
(p=0.008 and 0.004). Since fMLP and plasma are granulocyte/
neutrophil chemotactics [20,29], we did not see significant
differences between them (Fig. 3B ) .T h e s ed a t ad e m o n s t r a t e s
that CBFCA permits the determination of the specific leukocyte
chemotactic activity of commercial and biological chemotactics.
Boyden chamber assays and flow cytometry have been
conjugated before for studying leukocyte chemotaxis [30];
however, none of these studies used the flow cytometric
analysis for the quantification and phenotypification of the
attracted leukocytes simultaneously. The specificity of CBFCA
for determining the phenotype of migrating leukocytes depends
of antibodies and cytometer used in each laboratory. All the
antibodies used were 97–100% specific.
Other advantages of CBFCA
Robustness. We evaluated the robustness of CBFCA by
quantifying the leukocyte chemotaxis of diluted and undiluted
plasma at different incubation times. Our results indicate that
undiluted plasma induced more leukocyte chemotactic activity
than diluted plasma at 60, 90 or 120 min of incubation (p,0.005)
(Fig. 4 A). These results indicate that CBFCA is robust enough to
quantify the attracted leukocytes in a wide range of biological
concentrations of chemotactics. This represents an advantage
when small (and diluted) volumes of biological samples are
available for chemotaxis studies.
The choice of incubation time in the chemotaxis assays is
crucial for the evaluation of the number of attracted leukocytes
[31]. We performed time course experiments using undiluted and
diluted plasma. With this set of experiments, it was demonstrated
that the migration rate was higher at 60 than at 90 min of
incubation, regardless of using undiluted or diluted plasma
Figure 3. Specificity of CBFCA. CBFCA involves the determination of the leukocyte phenotype using conjugated specific antibodies and flow
cytometry. A) Representative dot-plots showing the dual parameters used for the flow cytometric analysis: CD45+ for total leukocytes, CD45+CD3+
for T-lymphocytes, CD45+CD14+ for monocytes, CD45+CD56+ for NK cells and CD45+CD19+ for B lymphocytes. B) Specific leukocyte chemotactic
activity of 10
26 M fMLP and plasma. Leukocyte subset proportions were significantly different before and after the assay. Data shown are means6SD
of five independent assays in triplicate. Significance was determined by ANOVA and Games-Howell test.
doi:10.1371/journal.pone.0028771.g003
Combined Boyden-Flow Cytometry Assay
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120 min of incubation when undiluted plasma is used (p,0.0001)
(Fig. 4 A). These results indicate that the incubation time for the
CBFCA depends of the chemoattractant concentration. More-
over, the fact that each leukocyte subset has different respon-
siveness to chemotaxis [7,21] should be considered. Since we
mostly use CBFCA with mixed leukocyte subsets, we performed
assays at three different incubation times, using total leukocytes
and undiluted plasma. We demonstrated that CFBCA had a
robust incubation time of 30 min, which comprised between the
90 and 120 min of incubation time. Thus, we observed that all
the leukocyte subsets reached the top of their migration within
90 min and their proportions did not change at 120 min of
incubation time (Fig 4 B). This represents an advantage of this
assay when the incubation time needs to be modified according
the experimental design. We also demonstrated that granulocytes
and B-lymphocytes completed their migration within the first
60 min (Fig 4 B). This represents an advantage of quick
incubation time when purified granulocyte or B lymphocyte
subsets are tested in CBFCA. 1:50 and 1:100 plasma dilutions
caused the same changes in proportions of leukocyte subsets (data
not shown).
Linearity. We demonstrated the linearity of CBFCA, using
purified neutrophils and monocytes and two concentrations of
fMLP (10
26 and 10
23 M). Our data showed that the number of
attracted neutrophils and monocytes increased lineally with the
starting number of cells. This is an important consideration of the
quantitative validity of the end-point measurements. As expected,
10
23 M fMLP attracted more leukocytes than 10
26 M fMLP in
all the cases (p,0.0001). This is further evidence of the sensitivity of
CBFCA, since we observed differences of leukocyte chemotactic
activity using the minimal starting number for attraction (500
cells). In addition, although the reported optimal concentration of
fMLP for migration is 10
26 M, we demonstrated that CBFCA
permitted testing of more concentrated chemotactics (10
23 M
fMLP). This represents other evidence of robustness in CBFCA
(Fig. 5). We recommend the optimization of leukocyte and
chemotactic concentrations before using this assay.
Performance Time. The time required for sample
preparation and incubations are similar in CBCA and CBFCA.
However, the time required for staining and cell counting in the
latter is reduced by 2–3 hours. This indicates that not only does
the CBCFA method provide important additional information
regarding leukocyte phenotype; it can be performed in
approximately half the time required for the CBCA.
CBFCA does not require albumin. Many researchers have
utilized human albumin (HA) to facilitate the chemotaxis process
[8,22,23,24,25,26]. However, these previous investigations did not
consider that HA could confound or mask the chemotactic activity
of specific chemotactics. Figure 6 demonstrates the interaction
between HA and fMLP on leukocyte chemotaxis evaluated by
CBFCA. Albumin itself has significant chemotactic activity
(Figure 6, white bars). However, in the presence of 2% HA, the
chemoattractant activity of the standard chemical chemotactic
agent fMLP was significantly underestimated or ‘‘masked’’
(Figure 6, gray bars). Thus, all our assays were performed
without HA to enable a clear evaluation of the biological
chemotactic activity. Although the addition of HA has been
recommended in assays with monocytes to maintain their viability
[32], we suggest avoiding its use for the proposed CBFCA.
Disadvantages of CBFCA
As mentioned CBFCA is a modern assay and therefore there is
also a disadvantage; it is more expensive than CBCA since it
involves the use of antibodies and flow cytometry. Flow cytometry
performance also requires a trained operator and reagents.
Overall, we consider that the advantages offered by using CBFCA
compensated for the expensiveness of this assay.
In summary, we have demonstrated that CBFCA is a precise,
specific, sensitive, and robust tool for the in vitro quantification of
leukocyte chemotactic activity. Our method enables rapid
quantification and simultaneous phenotypification of migrating
leukocytes, and it is adaptable to biological samples and
commercial chemotactics. Importantly, this is the first method
that permits the recovery of migrating leukocytes for subsequent
analysis and characterization. Knowing the pattern and phenotype
Figure 4. A) Robustness of CBFCA. To investigate the robustness of CBFCA the leukocyte chemotactic activity of undiluted and diluted plasma
was determined in time course experiments. CBFCA was able to determine the biological chemotactic activity of diluted and undiluted plasma at 60,
90 and 120 min. B) Robustness of the incubation time in CBFCA. CBFCAs were performed at different incubation times (60, 90 and 120 min) using
total leukocytes and plasma. All the leukocyte subsets reached the top of their migration within 90 min and their proportions did not change at
120 min of incubation time. Granulocytes and B-lymphocytes completed their migration within the first 60 min. Data shown are means6SD of five
independent assays in triplicate. Means with same symbol are significantly different. Significance was determined by ANOVA and Games-Howell tests
(p#{{c¥ 0.0001, l 0.005).
doi:10.1371/journal.pone.0028771.g004
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developed to target specific leukocyte subsets implicated in
immunopathological responses. In summary, the information
attainable by the routine use of this combined assay will further
our understanding of both the chemotaxis process and the
inflammatory response.
Figure 6. Effect of HA on leukocyte chemotaxis. CBFCAs were performed using medium or 10
26 M fMLP, in the absence or presence of 0.1%
and 2% HA. The addition of 2% HA to the medium and 10
26 M fMLP attracted more leukocytes; however, it also masked the chemotactic activity of
10
26 M fMLP. Data are shown as means6SD of five independent assays in triplicate. Means with same symbol are significantly different. Significance
was determined by ANOVA, Games-Howell tests and T test (p={{ 0.027).
doi:10.1371/journal.pone.0028771.g006
Figure 5. Linearity of CBFCA. CBFCAs were performed using 10
23 and 10
26 M fMLP as chemotactic and purified neutrophils (A) and monocytes
(B) at different concentrations. The number of attracted neutrophils and monocytes increased lineally with the starting number of cells. Significantly
more leukocytes were attracted by 10
23 M fMLP than by 10
26 M fMLP in all the cases. Data shown are means6SD of four independent assays in
triplicate. Significance was determined by T test.
doi:10.1371/journal.pone.0028771.g005
Combined Boyden-Flow Cytometry Assay
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